| Year |
Citation |
Score |
| 2023 |
Zhao W, Yeatts SD, Broderick JP, Selim MH, Adeoye OM, Durkalski-Mauldin VL, Meinzer CN, Martin RH, Dillon CR, Cassarly CN, Pauls KH, Elm JJ. Optimal Randomization Designs for Large Multicenter Clinical Trials: From the National Institutes of Health Stroke Trials Network Funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke Experience. Stroke. PMID 37078281 DOI: 10.1161/STROKEAHA.122.040743 |
0.352 |
|
| 2020 |
Liu J, Wick J, Martin RH, Meinzer C, Roy D, Gajewski B. Correction to: Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials. Bmc Medical Research Methodology. 20: 227. PMID 32912172 DOI: 10.1186/S12874-020-01114-8 |
0.37 |
|
| 2020 |
Liu J, Wick J, Martin RH, Meinzer C, Roy D, Gajewski B. Two-stage Bayesian hierarchical modeling for blinded and unblinded safety monitoring in randomized clinical trials. Bmc Medical Research Methodology. 20: 211. PMID 32807102 DOI: 10.1186/S12874-020-01097-6 |
0.324 |
|
| 2020 |
Yeatts SD, Martin RH, Meurer W, Silbergleit R, Rockswold G, Barsan WG, Korley FK, Wright D, Gajewski BJ. Sliding Scoring of the Glasgow Outcome Scale - Extended (GOS-E) as Primary Outcome in Traumatic Brain Injury Trials. Journal of Neurotrauma. PMID 32664792 DOI: 10.1089/Neu.2019.6969 |
0.358 |
|
| 2020 |
Almallouhi E, Al Kasab S, Yamada L, Martin RH, Turan TN, Chimowitz MI. Relationship Between Vascular Risk Factors and Location of Intracranial Atherosclerosis in the SAMMPRIS Trial. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 104713. PMID 32089436 DOI: 10.1016/J.Jstrokecerebrovasdis.2020.104713 |
0.359 |
|
| 2019 |
Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, Suarez JI, Qureshi AI, Palesch YY, Anderson CS. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. The Lancet. Neurology. 18: 857-864. PMID 31397290 DOI: 10.1016/S1474-4422(19)30196-6 |
0.377 |
|
| 2019 |
Graham EM, Martin RH, Buckley JR, Zyblewski SC, Kavarana MN, Bradley SM, Alsoufi B, Mahle WT, Hassid M, Atz AM. Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Randomized Controlled Trial. Journal of the American College of Cardiology. 74: 659-668. PMID 31370958 DOI: 10.1016/J.Jacc.2019.05.060 |
0.342 |
|
| 2019 |
Morotti A, Shoamanesh A, Oliveira-Filho J, Schlunk F, Romero JM, Jessel M, Ayres A, Vashkevich A, Schwab K, Cassarly C, Martin RH, Greenberg SM, Qureshi AI, Rosand J, Goldstein JN, et al. White Matter Hyperintensities and Blood Pressure Lowering in Acute Intracerebral Hemorrhage: A Secondary Analysis of the ATACH-2 Trial. Neurocritical Care. PMID 31218636 DOI: 10.1007/S12028-019-00761-0 |
0.343 |
|
| 2019 |
Damani R, Mayer S, Dhar R, Martin RH, Nyquist P, Olson DM, Mejia-Mantilla JH, Muehlschlegel S, Jauch EC, Mocco J, Mutoh T, Suarez JI. Common Data Element for Unruptured Intracranial Aneurysm and Subarachnoid Hemorrhage: Recommendations from Assessments and Clinical Examination Workgroup/Subcommittee. Neurocritical Care. PMID 31090013 DOI: 10.1007/S12028-019-00736-1 |
0.351 |
|
| 2019 |
Gajewski BJ, Meinzer C, Berry SM, Rockswold GL, Barsan WG, Korley FK, Martin RH. Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials. Statistics in Medicine. PMID 31070807 DOI: 10.1002/Sim.8167 |
0.358 |
|
| 2018 |
Moullaali TJ, Wang X, Martin RH, Shipes VB, Qureshi AI, Anderson CS, Palesch YY. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018813695. PMID 30418098 DOI: 10.1177/1747493018813695 |
0.366 |
|
| 2018 |
Bauza C, Martin R, Yeatts SD, Borg K, Magwood G, Selassie A, Ford ME. Determining the Joint Effect of Obesity and Diabetes on All-Cause Mortality and Cardiovascular-Related Mortality following an Ischemic Stroke. Stroke Research and Treatment. 2018: 4812712. PMID 30174819 DOI: 10.1155/2018/4812712 |
0.325 |
|
| 2018 |
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY. Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. Journal of Biopharmaceutical Statistics. 1-16. PMID 29985739 DOI: 10.1080/10543406.2018.1489404 |
0.446 |
|
| 2018 |
Bauza C, Yeatts SD, Borg K, Magwood G, Martin RH, Selassie A, Ford ME. Determining the joint effect of obesity and diabetes on functional disability at 3-months and on all-cause mortality at 1-year following an ischemic stroke. Bmc Endocrine Disorders. 18: 40. PMID 29914457 DOI: 10.1186/S12902-018-0255-1 |
0.349 |
|
| 2018 |
Shoamanesh A, Morotti A, Romero JM, Oliveira-Filho J, Schlunk F, Jessel MJ, Ayres AM, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Martin RH, Qureshi AI, Greenberg SM, Rosand J, et al. Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes: A Secondary Analysis of the ATACH-2 Randomized Clinical Trial. Jama Neurology. PMID 29710119 DOI: 10.1001/Jamaneurol.2018.0454 |
0.392 |
|
| 2017 |
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY. Assessing type I error and power of multistate Markov models for panel data-A simulation study. Communications in Statistics: Simulation and Computation. 46: 7040-7061. PMID 29225407 DOI: 10.1080/03610918.2016.1222425 |
0.324 |
|
| 2017 |
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY. Comparison of multistate Markov modeling with contemporary outcomes in a reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Plos One. 12: e0187050. PMID 29073195 DOI: 10.1371/Journal.Pone.0187050 |
0.468 |
|
| 2017 |
Meinzer C, Martin R, Suarez JI. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization. Trials. 18: 420. PMID 28886745 DOI: 10.1186/S13063-017-2004-6 |
0.322 |
|
| 2017 |
Morotti A, Boulouis G, Romero JM, Brouwers HB, Jessel MJ, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Greenberg SM, Martin RH, Qureshi AI, Rosand J, Goldstein JN. Blood pressure reduction and noncontrast CT markers of intracerebral hemorrhage expansion. Neurology. PMID 28701501 DOI: 10.1212/Wnl.0000000000004210 |
0.315 |
|
| 2017 |
Morotti A, Brouwers HB, Romero JM, Jessel MJ, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Greenberg SM, Martin RH, Qureshi AI, Rosand J, Goldstein JN. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial. Jama Neurology. PMID 28628707 DOI: 10.1001/Jamaneurol.2017.1014 |
0.373 |
|
| 2017 |
Al Kasab S, Cassarly C, Le NA, Martin R, Brinley J, Chimowitz MI, Turan TN. Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 28089094 DOI: 10.1016/J.Jstrokecerebrovasdis.2016.12.006 |
0.329 |
|
| 2017 |
Palesch Y, Ramakrishnan V, Foster L, Martin R, Cassarly C, Barsan W, Moy C, Qureshi A. Antihypertensive treatment of acute cerebral hemorrhage phase iii (ATACH-II) trial: Secondary analysis of Asian and non-Asian subgroups using 24-hour blood pressure profile data Journal of the Neurological Sciences. 381: 643. DOI: 10.1016/J.Jns.2017.08.1811 |
0.386 |
|
| 2016 |
Martin RH, Yeatts SD, Hill MD, Moy CS, Ginsberg MD, Palesch YY. ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke; a Journal of Cerebral Circulation. PMID 27462118 DOI: 10.1161/STROKEAHA.116.012825 |
0.396 |
|
| 2016 |
Gajewski BJ, Berry SM, Barsan WG, Silbergleit R, Meurer WJ, Martin R, Rockswold GL. Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling. Pharmaceutical Statistics. PMID 27306921 DOI: 10.1002/Pst.1755 |
0.397 |
|
| 2015 |
Turan TN, LeMatty T, Martin R, Chimowitz MI, Rumboldt Z, Spampinato MV, Stalcup S, Adams RJ, Brown T. Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study - rationale and design. Brain and Behavior. 5: e00397. PMID 26807333 DOI: 10.1002/Brb3.397 |
0.329 |
|
| 2015 |
Jenkins DD, Wiest DB, Mulvihill DM, Hlavacek AM, Majstoravich SJ, Brown TR, Taylor JJ, Buckley JR, Turner RP, Rollins LG, Bentzley JP, Hope KE, Barbour AB, Lowe DW, Martin RH, et al. Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis. The Journal of Pediatrics. PMID 26545726 DOI: 10.1016/J.Jpeds.2015.09.076 |
0.318 |
|
| 2015 |
Hill MD, Martin RH, Palesch YY, Moy CS, Tamariz D, Ryckborst KJ, Jones EB, Weisman D, Pettigrew C, Ginsberg MD. Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. Plos One. 10: e0131390. PMID 26325387 DOI: 10.1371/Journal.Pone.0131390 |
0.443 |
|
| 2015 |
Yeatts SD, Martin RH. What is missing from my missing data plan? Stroke; a Journal of Cerebral Circulation. 46: e130-2. PMID 25953373 DOI: 10.1161/Strokeaha.115.007984 |
0.419 |
|
| 2015 |
Lazaridis C, Maas AI, Souter MJ, Martin RH, Chesnut RM, DeSantis SM, Sung G, Leroux PD, Suarez JI. Alternative clinical trial design in neurocritical care. Neurocritical Care. 22: 378-84. PMID 25894451 DOI: 10.1007/S12028-015-0135-8 |
0.355 |
|
| 2015 |
Suarez JI, Martin RH, Calvillo E, Bershad EM, Venkatasubba Rao CP. Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study. Acta Neurochirurgica. Supplement. 120: 287-90. PMID 25366638 DOI: 10.1007/978-3-319-04981-6_48 |
0.313 |
|
| 2015 |
Ciolino JD, Martin RH, Zhao W, Hill MD, Jauch EC, Palesch YY. Measuring continuous baseline covariate imbalances in clinical trial data. Statistical Methods in Medical Research. 24: 255-72. PMID 21865270 DOI: 10.1177/0962280211416038 |
0.62 |
|
| 2014 |
Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, et al. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. Journal of Neurointerventional Surgery. PMID 25342652 DOI: 10.1136/Neurintsurg-2014-011318 |
0.312 |
|
| 2014 |
Simpson KN, Simpson AN, Mauldin PD, Hill MD, Yeatts SD, Spilker JA, Foster LD, Khatri P, Martin R, Jauch EC, Kleindorfer D, Palesch YY, Broderick JP. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 45: 1791-8. PMID 24876261 DOI: 10.1161/Strokeaha.113.003874 |
0.381 |
|
| 2014 |
Estol CJ, Bath PM, Gorelick PB, Cotton D, Martin RH, Weber MA, Dahlof B. Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study. Blood Pressure Monitoring. 19: 256-62. PMID 24736279 DOI: 10.1097/Mbp.0000000000000045 |
0.39 |
|
| 2014 |
Yeatts SD, Martin RH, Coffey CS, Lyden PD, Foster LD, Woolson RF, Broderick JP, Di Tullio MR, Jungreis CA, Palesch YY. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke; a Journal of Cerebral Circulation. 45: 1408-14. PMID 24699059 DOI: 10.1161/Strokeaha.113.003925 |
0.47 |
|
| 2014 |
Estol CJ, Bath PMW, Gorelick PB, Martin RH, Diener HC, Bath P, Donnan GA, Cotton D, Estol C, Hilbrich L, Humphreys M, Ôunpuu S, Roberts R, Teal P, Toni D, et al. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial International Journal of Stroke. 9: 43-47. PMID 24636673 DOI: 10.1111/Ijs.12269 |
0.403 |
|
| 2014 |
Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Continuous covariate imbalance and conditional power for clinical trial interim analyses. Contemporary Clinical Trials. 38: 9-18. PMID 24607294 DOI: 10.1016/J.Cct.2014.02.007 |
0.639 |
|
| 2014 |
Suarez JI, Martin RH, Calvillo E, Zygun D, Flower O, Wong GK, Bershad EM, Venkatasubba Rao CP, Georgiadis A, Jichici D, Leroux PD. Human albumin administration in subarachnoid hemorrhage: results of an international survey. Neurocritical Care. 20: 277-86. PMID 24378920 DOI: 10.1007/S12028-013-9942-Y |
0.313 |
|
| 2014 |
Qureshi AI, Majidi S, Gilani WI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N. Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study. Neurocritical Care. 20: 470-5. PMID 23609118 DOI: 10.1007/S12028-013-9842-1 |
0.327 |
|
| 2013 |
Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. Journal of Biopharmaceutical Statistics. 23: 1383-402. PMID 24138438 DOI: 10.1080/10543406.2013.834912 |
0.612 |
|
| 2013 |
Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, Waldman BD, Tamariz D, Ryckborst KJ. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. The Lancet. Neurology. 12: 1049-58. PMID 24076337 DOI: 10.1016/S1474-4422(13)70223-0 |
0.465 |
|
| 2013 |
Jenkins DD, Lee T, Chiuzan C, Perkel JK, Rollins LG, Wagner CL, Katikaneni LP, Bass WT, Kaufman DA, Horgan MJ, Laungani S, Givelichian LM, Sankaran K, Yager JY, Martin R. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy*. Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 14: 786-95. PMID 23897243 DOI: 10.1097/Pcc.0B013E3182975Cc9 |
0.411 |
|
| 2013 |
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, ... ... Martin RH, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine. 368: 893-903. PMID 23390923 DOI: 10.1056/Nejmoa1214300 |
0.322 |
|
| 2012 |
Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 11: 942-50. PMID 23051991 DOI: 10.1016/S1474-4422(12)70225-9 |
0.429 |
|
| 2012 |
Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke; a Journal of Cerebral Circulation. 43: 683-90. PMID 22267829 DOI: 10.1161/Strokeaha.111.633958 |
0.396 |
|
| 2011 |
Ovbiagele B, Diener HC, Yusuf S, Martin RH, Cotton D, Vinisko R, Donnan GA, Bath PM. Level of systolic blood pressure within the normal range and risk of recurrent stroke Jama - Journal of the American Medical Association. 306: 2137-2144. PMID 22089721 DOI: 10.1001/Jama.2011.1650 |
0.389 |
|
| 2011 |
Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N, Liu Y. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocritical Care. 15: 428-35. PMID 21573860 DOI: 10.1007/S12028-011-9541-8 |
0.312 |
|
| 2011 |
Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ, Moy CS, Barsan WG, Ginsberg MD. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke; a Journal of Cerebral Circulation. 42: 1621-5. PMID 21546491 DOI: 10.1161/Strokeaha.110.610980 |
0.484 |
|
| 2011 |
Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, Yeatts SD, Tamariz D, Ryckborst K. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke; a Journal of Cerebral Circulation. 42: 119-27. PMID 21164127 DOI: 10.1161/Strokeaha.110.596072 |
0.442 |
|
| 2011 |
Ciolino J, Zhao W, Martin R, Palesch Y. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemporary Clinical Trials. 32: 250-9. PMID 21078415 DOI: 10.1016/J.Cct.2010.11.005 |
0.655 |
|
| 2010 |
Suarez JI, Martin RH. Treatment of Subarachnoid Hemorrhage with Human Albumin: ALISAH Study. Rationale and Design Neurocritical Care. 13: 263-277. PMID 20535587 DOI: 10.1007/S12028-010-9392-8 |
0.371 |
|
| 2010 |
Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Archives of Neurology. 67: 570-6. PMID 20457956 DOI: 10.1001/Archneurol.2010.61 |
0.357 |
|
| 2010 |
Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 41: 732-8. PMID 20181679 DOI: 10.1161/Strokeaha.109.564906 |
0.397 |
|
| 2010 |
Novitzke J, Martin R, Palesch YY, Qureshi AI. Clinical site activation times for multicenter clinical trials: Lessons learned from the Antihypertensive Treatment of Acute Cerebral Hemorrhage trial Journal of Neuroscience Nursing. 42: E17-E22. DOI: 10.1097/Jnn.0B013E3181D5Befa |
0.326 |
|
| 2009 |
Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 40: 3541-6. PMID 19797187 DOI: 10.1161/Strokeaha.109.555623 |
0.43 |
|
| 2008 |
Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. The Lancet. Neurology. 7: 875-84. PMID 18757238 DOI: 10.1016/S1474-4422(08)70198-4 |
0.406 |
|
| 2008 |
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. The New England Journal of Medicine. 359: 1225-37. PMID 18753639 DOI: 10.1056/Nejmoa0804593 |
0.378 |
|
| 2008 |
Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England Journal of Medicine. 359: 1238-51. PMID 18753638 DOI: 10.1056/Nejmoa0805002 |
0.366 |
|
| 2007 |
Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, Patterson L, Mendez IM, Ryckborst KJ, Tamariz D, Ginsberg MD. The albumin in acute stroke trial (ALIAS); design and methodology. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 214-9. PMID 18705947 DOI: 10.1111/J.1747-4949.2007.00143.X |
0.443 |
|
| Show low-probability matches. |